{
    "2020-09-28": [
        [
            {
                "time": "",
                "original_text": "两家知名药企围绕50亿大品种的改良新药开展合作",
                "features": {
                    "keywords": [
                        "药企",
                        "改良新药",
                        "合作"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "恒指收涨1.04% 楼宇建造板块领涨",
                "features": {
                    "keywords": [
                        "恒指",
                        "收涨",
                        "楼宇建造",
                        "领涨"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "房地产",
                        "建筑"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "东阳光药、华海……60个新药获批临床！国产1类新药大爆发",
                "features": {
                    "keywords": [
                        "东阳光药",
                        "华海",
                        "新药",
                        "临床",
                        "爆发"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "药企爆发“创新潮”，大批新药获批临床",
                "features": {
                    "keywords": [
                        "药企",
                        "创新潮",
                        "新药",
                        "临床"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "大摩：升复星国际（00656）目标价至11港元 评级“增持”",
                "features": {
                    "keywords": [
                        "大摩",
                        "复星国际",
                        "目标价",
                        "增持"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合企业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "大摩：复星国际目标价升至11港元 维持增持评级",
                "features": {
                    "keywords": [
                        "大摩",
                        "复星国际",
                        "目标价",
                        "增持"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合企业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "复星陈启宇：我们的目标是让人们健康活到121岁",
                "features": {
                    "keywords": [
                        "复星",
                        "陈启宇",
                        "健康",
                        "目标"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2023-09-28",
                "original_text": "智通港股通持股分析|9月28日",
                "features": {
                    "keywords": [
                        "智通",
                        "港股通",
                        "持股分析"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "市场整体"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "融资盘小幅流出 节前风险偏好受抑制",
                "features": {
                    "keywords": [
                        "融资盘",
                        "流出",
                        "风险偏好",
                        "抑制"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "市场整体"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-09-28",
                "original_text": "智通港股投资日记|9月28日",
                "features": {
                    "keywords": [
                        "智通",
                        "港股投资",
                        "日记"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "市场整体"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}